SPL
BIIB icon

Superior Planning, LLC’s Biogen BIIB Stock Holding History

Superior Planning, LLC’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$4.52K Buy
+20
New +$4.24K ﹤0.01% 1239

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $161B AUM 86.05% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $111B AUM 30.48% 1-Year Est. Return

Superior Planning, LLC's BIIB Position: Q3 2026 in Review

Superior Planning, LLC opened a new position in Biogen (BIIB) in Q3 2026: 20 shares worth $4.52K. The stake represents ﹤0.01% of the portfolio and ranks #1239 among its holdings.

765 funds tracked by Wall St. Rank hold BIIB as of Q3 2026.

  • Superior Planning, LLC held 20 shares of Biogen worth $4.52K as of Q3 2026.
  • Biogen was a new Superior Planning, LLC position in Q3 2026.
  • Biogen made up ﹤0.01% of Superior Planning, LLC's portfolio in Q3 2026, its #1239 holding.
  • 765 funds tracked by Wall St. Rank held Biogen as of Q3 2026.

Based on Superior Planning, LLC's 13F filing for Q3 2026, filed 12 Nov 2026.